Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Teva Pharmaceutical Industries Ltd (ADR) (TEVA)  
$13.81 0.56 (4.23%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,095,971,000
Market Cap: 15.14(B)
Last Volume: 10,278,701 Avg Vol: 10,598,169
52 Week Range: $7.2 - $14.43
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ-100     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 677,343 677,343 767,191 1,433,490
Total Sell Value $8,974,605 $8,974,605 $9,773,842 $16,030,825
Total People Sold 8 8 8 11
Total Sell Transactions 14 14 17 32
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 521
  Page 10 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Dethlefs Sven EVP Global Marketing&Portfolio   •       –      –    2021-03-03 4 AS $10.86 $6,583 D/D (606) 70,058 -17%     
   Dethlefs Sven EVP Global Marketing&Portfolio   •       –      –    2021-03-03 4 OE $0.00 $0 D/D 1,400 70,664     -
   Nazzi Gianfranco EVP, International Markets   •       –      –    2021-03-03 4 AS $10.88 $15,231 D/D (1,400) 0 -17%     
   Nazzi Gianfranco EVP, International Markets   •       –      –    2021-03-03 4 OE $0.00 $0 D/D 1,400 1,400     -
   Daniell Richard Exec. VP, European Commercial   •       –      –    2021-03-03 4 AS $10.88 $10,803 D/D (993) 11,873 -17%     
   Daniell Richard Exec. VP, European Commercial   •       –      –    2021-03-03 4 OE $0.00 $0 D/D 2,101 12,866     -
   Ogrady Brendan P. EVP, North America Commercial   •       –      –    2021-03-02 4 AS $10.85 $163,601 D/D (15,085) 14,868 -13%     
   Fridriksdottir Hafrun Executive VP, Global R&D   •       –      –    2021-03-02 4 AS $10.82 $540,890 D/D (50,000) 64,064 -13%     
   Drape Eric Executive VP Global Operations   •       –      –    2021-03-01 4 AS $10.85 $106,285 D/D (9,795) 49,291 -15%     
   Stark David Matthew Exec. VP Chief Legal Officer   •       –      –    2021-03-01 4 AS $10.83 $199,612 D/D (18,430) 2,974 -15%     
   Dethlefs Sven EVP Global Marketing&Portfolio   •       –      –    2021-03-01 4 AS $10.83 $81,079 D/D (7,486) 69,264 -15%     
   Ogrady Brendan P. EVP, North America Commercial   •       –      –    2021-03-01 4 AS $10.83 $798,023 D/D (73,127) 29,953 -15%     
   Nazzi Gianfranco EVP, International Markets   •       –      –    2021-03-01 4 AS $10.85 $821,925 D/D (75,587) 0 -15%     
   Fridriksdottir Hafrun Executive VP, Global R&D   •       –      –    2021-03-01 4 AS $10.83 $118,186 D/D (10,912) 114,064 -15%     
   Daniell Richard Exec. VP, European Commercial   •       –      –    2021-03-01 4 AS $10.85 $223,507 D/D (20,598) 10,765 -15%     
   Drape Eric Executive VP Global Operations   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 19,514 59,086     -
   Stark David Matthew Exec. VP Chief Legal Officer   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 18,430 21,404     -
   Kalif Eliyahu Sharon EVP, Chief Financial Officer   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 18,430 18,430     -
   Schultz Kare President and CEO   •       •      –    2021-02-28 4 OE $0.00 $0 D/D 65,047 800,881     -
   Dethlefs Sven EVP Global Marketing&Portfolio   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 17,346 76,750     -
   Ogrady Brendan P. EVP, North America Commercial   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 24,934 103,080     -
   Nazzi Gianfranco EVP, International Markets   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 15,177 75,587     -
   Fridriksdottir Hafrun Executive VP, Global R&D   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 21,682 124,976     -
   Sabag Mark See Remarks below   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 20,598 131,922     -
   Daniell Richard Exec. VP, European Commercial   •       –      –    2021-02-28 4 OE $0.00 $0 D/D 20,598 31,363     -
  521 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us